Response Predictive Markers and Synergistic Agents for Drug Repositioning of Statins in Ovarian Cancer
In the field of drug repurposing, the use of statins for treating dyslipidemia is considered promising in ovarian cancer treatment based on epidemiological studies and basic research findings. Biomarkers should be established to identify patients who will respond to statin treatment to achieve clini...
保存先:
主要な著者: | , , , , , , , , , , , , |
---|---|
フォーマット: | 図書 |
出版事項: |
MDPI AG,
2022-01-01T00:00:00Z.
|
主題: | |
オンライン・アクセス: | Connect to this object online. |
タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|
インターネット
Connect to this object online.3rd Floor Main Library
請求記号: |
A1234.567 |
---|---|
所蔵 1 | 利用可 |